How is BIA-ALCL treated once it is diagnosed?
The mainstay is surgery that removes the implant and the intact capsule together, and outcomes reported for disease caught early are favorable.
BIA-ALCL is a rare lymphoma that arises in the fluid and capsule around textured breast implants. It is highly treatable, and the core of treatment is surgical: taking out the implant and the capsule around it as one intact specimen.
Surgery first, systemic therapy only when needed
Diagnosis starts with ultrasound and aspiration of the fluid around the implant, tested for the CD30 marker. Once confirmed, the standard operation is en-bloc resection — implant and intact capsule removed together — with staging scans beforehand; many teams also discuss removing the opposite implant during the same surgery. For disease confined to the capsule, complete surgery alone is the mainstay, and reported outcomes in early-stage patients are favorable.
When disease extends beyond the capsule or lymph nodes are involved, hematology-oncology joins the team and chemotherapy or targeted therapy may follow surgery. Prognosis and follow-up schedules vary with stage and individual factors, so care belongs in a multidisciplinary setting — if you have been told you have a suspicious fluid collection, seek consultation at a center experienced with this diagnosis.
MediIndex articles are for general information only and are not medical advice, diagnosis, or advertising. Outcomes vary by individual — consult a board-certified specialist for personal decisions.